Literature DB >> 7793108

Testosterone deficiency and extreme retardation of puberty in homozygous sickle-cell disease.

A Singhal1, L Gabay, G R Serjeant.   

Abstract

Homozygous sickle-cell (SS) disease is associated with retardation of physical and sexual development but most Jamaican SS children commence their adolescent growth spurt before 16 years of age. Analysis of growth data from children in the Jamaican Cohort Study noted extreme growth retardation, defined as absence of the adolescent growth spurt and pre-pubertal sexual development (Tanner stage 1 or 2) at age 16 years, in 8/52 (15%) SS boys. These and two boys from the general sickle-cell clinic with a similar growth pattern provided a study group of 10 boys who were investigated for a possible endocrine explanation for their extreme retardation of physical maturation. A sub-optimal testosterone response (< 10 nmol/l) to human chorionic gonadotrophin and an exaggerated gonadotrophin response to gonadotrophin hormone releasing hormone was consistent with poor testicular function in 5 boys. Retardation of adolescent growth and development is common in boys with SS disease but, when extreme, requires early investigation to identify potentially correctable mechanisms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7793108

Source DB:  PubMed          Journal:  West Indian Med J        ISSN: 0043-3144            Impact factor:   0.171


  7 in total

Review 1.  Molecular pathophysiology of priapism: emerging targets.

Authors:  Uzoma A Anele; Belinda F Morrison; Arthur L Burnett
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Testosterone replacement in transgenic sickle cell mice controls priapic activity and upregulates PDE5 expression and eNOS activity in the penis.

Authors:  B Musicki; S Karakus; W Akakpo; F H Silva; J Liu; H Chen; B R Zirkin; A L Burnett
Journal:  Andrology       Date:  2017-11-16       Impact factor: 3.842

3.  Is testosterone deficiency a possible risk factor for priapism associated with sickle-cell disease?

Authors:  Belinda F Morrison; Uzoma A Anele; Marvin E Reid; Wendy A Madden; Zhaoyong Feng; Arthur L Burnett
Journal:  Int Urol Nephrol       Date:  2014-11-05       Impact factor: 2.370

Review 4.  Testosterone Deficiency in Sickle Cell Disease: Recognition and Remediation.

Authors:  Biljana Musicki; Arthur L Burnett
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-03       Impact factor: 6.055

5.  Mechanism of testosterone deficiency in the transgenic sickle cell mouse.

Authors:  Biljana Musicki; Yuxi Zhang; Haolin Chen; Terry R Brown; Barry R Zirkin; Arthur L Burnett
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

6.  Predictors of abnormal bone mass density in adult patients with homozygous sickle-cell disease.

Authors:  Taysir S Garadah; Adla B Hassan; Ahmed A Jaradat; Diab E Diab; Hiba O Kalafalla; Adel K Kalifa; Reginald P Sequeira; Abdul Hameed A Alawadi
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2015-05-07

Review 7.  Growth and Growth hormone - Insulin Like Growth Factor -I (GH-IGF-I) Axis in Chronic Anemias.

Authors:  Ashraf T Soliman; Vincenzo De Sanctis; Mohamed Yassin; Ashraf Adel
Journal:  Acta Biomed       Date:  2017-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.